David Narrow

David Narrow is the current CEO at Sonavex, a previous company they worked for called Canopy, and Health Advances. David has also worked for MonoMano, Inc. and Julius Wolff Institut, Charité - Universitätsmedizin Berlin. David has experience in strategy consulting and focused in healthcare. David has created and presented pieces of client presentations, developed revenue projections, P&Ls, and system economic models. David also has experience in conducting primary research across a variety of clinical and industry experts including detailed interviews and surveys.

David Narrow earned their MSE in Bioengineering Innovation & Design from The Johns Hopkins University and their B.S. in Biomedical Engineering from the [University of Rochester. David also attended The Park School.

Some direct reports include Katy Feeny - Director, Clinical Affairs, Alex Yevzlin - Chief Medical Officer, and Xin Kang - Director, Research & Development.